Newly designed genetic therapy could alleviate debilitating giant moles in rare skin condition

FHS
June 17, 2024
2:48 pm

Researchers at the Francis Crick Institute, UCL Great Ormond Street Institute for Child Health and Great Ormond Street Hospital for Children (GOSH) have designed a new genetic therapy that could alleviate debilitating giant moles in a rare skin condition.

Adjuvant Pembrolizumab Boosts DFS in High-Risk Muscle Invasive Urothelial Cancer

SAN FRANCISCO — The use of adjuvant pembrolizumab (Keytruda) more than doubled disease-free survival (DFS) in high-risk muscle-invasive urothelial carcinoma (MIUC) after radical surgery, according

January 29, 2024

An FDA pathway can accelerate innovation for Duchenne muscular dystrophy

In human biology, the protein dystrophin is a shining example of Joni Mitchell’s classic line, “you don’t know what you’ve got ’til it’s gone.” Dystrophin

April 22, 2024

Analytical testing: Ten questions that accelerate drug development – Pharmaceutical Technology

Share this article The pharmaceutical industry is already highly competitive. It’s a business driven by the compassionate desire to discover and develop therapies to improve

November 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.